In Soma Bio, Inc. announced it raised $202,000 in an initial filing from an offering of $202,000

Company

Location

About

inSoma Bio is a Duke University spinout and YC-backed company striving to build breast implants, personalized lumpectomy molds, and repair other soft tissue defects using a person’s own tissue without the need for major reconstructive surgery. We have developed an injectable gel that allows plastic surgeons to reliably build new tissue using a patient’s own liposuctioned fat without the need for synthetic implants or major reconstructive surgery.